Edgewise Therapeutics, Inc. (EWTX) stock
EWTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$42.04−1.64 (-3.75%)
Close on Nov 17, 2026Market cap $4.57BP/E –Yield –
Edgewise Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Edgewise Therapeutics's price to book ratio was 11.4× on Nov 11, 2026, against 4.9× a year earlier. Over the last 5 years it ranged from 1.2× to 11.4×, with a median of 3.1×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 11.4× | +6.7 |
| 2025 | Dec 31, 2025 | 4.7× | −0.5 |
| 2024 | Dec 31, 2024 | 5.2× | +2.8 |
| 2023 | Dec 29, 2023 | 2.4× | +0.8 |
| 2022 | Dec 30, 2022 | 1.6× | −1.1 |
| 2021 | Dec 31, 2021 | 2.6× | – |
See a number that looks wrong?